New Alzheimer’s treatment targets identified
1 min readPhoto caption: A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer’s disease, […] Cruchaga Lab. Article by Jim Dryden. July 8, 2021.
Study points to FDA-approved drugs that have potential to slow or reverse brain damage
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer’s disease, as well as existing drugs that have therapeutic potential against these targets.
The potential targets are defective proteins that lead to the buildup of amyloid in the brain, contributing to the onset of problems with memory and thinking that are the hallmark of Alzheimer’s. The 15 existing drugs identified by the researchers have been approved by the Food and Drug Administration (FDA) for other purposes, providing the possibility of clinical trials that could begin sooner than is typical, according to the researchers. […]